Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 9, 2000 - Issue 4
Submit an article Journal homepage
42
Views
9
CrossRef citations to date
0
Altmetric
Miscellaneous

Ongoing trials in Alzheimer’s disease

John J Sramek California Clinical Trials, 8500 Wilshire Boulevard, 7th Floor, Beverly Hills, CA 90211, USA. [email protected]
&
Neal R Cutler California Clinical Trials, 8500 Wilshire Boulevard, 7th Floor, Beverly Hills, CA 90211, USA. [email protected]
Pages 899-915 | Published online: 24 Feb 2005

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

John J Sramek, Amy E Veroff & Neal R Cutler. (2001) The status of ongoing trials for mild cognitive impairment. Expert Opinion on Investigational Drugs 10:4, pages 741-752.
Read now

Articles from other publishers (8)

Maria do Carmo Carreiras, Lhassane Ismaili & José Marco-Contelles. (2020) Propargylamine-derived multi-target directed ligands for Alzheimer’s disease therapy. Bioorganic & Medicinal Chemistry Letters 30:3, pages 126880.
Crossref
Haythem A. Saadeh, Mohammad A. Khasawneh, Abdelouahid Samadi, Ismail A. El-Haty, Grzegorz Sata?a, Andrzej J. Bojarski, Lhassane Ismaili, ?scar M. Bautista-Aguilera, Matilde Ya?ez, Jordi Mestres & Jos? Marco-Contelles. (2017) Design, Synthesis and Biological Evaluation of Potent Antioxidant 1-(2,5-Dimethoxybenzyl)-4-arylpiperazines and N -Azolyl Substituted 2-(4-Arylpiperazin-1-yl) . ChemistrySelect 2:13, pages 3854-3859.
Crossref
John J. Sramek, Victoria Zarotsky & Neal R. Cutler. (2002) Review of drug development and therapeutic role of cholinesterase inhibitors in Alzheimer's disease. Drug Development Research 56:3, pages 347-353.
Crossref
Mohammad Hossain, Stanford S. Jhee, Thomas Shiovitz, Craig McDonald, Greg Sedek, Francoise Pommier & Neal R. Cutler. (2002) Estimation of the Absolute Bioavailability of Rivastigmine in Patients with Mild to Moderate Dementia of the Alzheimer???s Type. Clinical Pharmacokinetics 41:3, pages 225-234.
Crossref
Paul A Whittaker. (2001) From symptomatic treatments to causative therapy?. Current Opinion in Chemical Biology 5:4, pages 352-359.
Crossref
Bernd Moosmann, Thomas Skutella, Klaus Beyer & Christian Behl. (2001) Protective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death. Biological Chemistry 382:11.
Crossref
Neal R. Cutler & John J. Sramek. (2001) Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development. Progress in Neuro-Psychopharmacology and Biological Psychiatry 25:1, pages 27-57.
Crossref
. (2000) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 15:12, pages 1161-1168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.